Residual α-l-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients

This publication has 27 references indexed in Scilit:

• Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure
  Orphanet Journal of Rare Diseases, 2011
• Mucopolysaccharidosis I mutations in Chinese patients: identification of 27 novel mutations and 6 cases involving prenatal diagnosis
  Clinical Genetics, 2011
• IDUA mutational profiling of a cohort of 102 European patients with mucopolysaccharidosis type I: identification and characterization of 35 novel α-L-iduronidase (IDUA) alleles
  Human Mutation, 2011
• Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment
  Genetics and Molecular Biology, 2010
• Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure
  Bone Marrow Transplantation, 2007
• Can mucopolysaccharidosis type I disease severity be predicted based on a patient’s genotype? A comprehensive review of the literature
  Genetics in Medicine, 2003
• Enzyme-Replacement Therapy in Mucopolysaccharidosis I
  New England Journal of Medicine, 2001
• Genotype–phenotype correlations in mucopolysaccharidosis type I using enzyme kinetics, immunoquantification and in vitro turnover studies
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1998
• Molecular genetics of muccpolysaccharidosis type I: Diagnostic, clinical, and biological implications
  Human Mutation, 1995
• Structure and sequence of the human α-l-iduronidase gene
  Genomics, 1992